Skip to main content
user-generated· price

Stock of ultrasound device manufacturer rises 25% within 12 months of…

Market overview

Shares of the company producing the ultrasound TTTS treatment device, likely a medical technology firm partnered with Imperial College, will surge by at least 25% following FDA clearance, driven by market optimism about the device's commercial potential and adoption prospects.

price prediction market

Implied probability (Yes)
55%
Closes
2028-07-10

More price markets

Browse all price markets →

Loading…